サポート ブログ AI Protein Structure Modeling Platforms in Antibody Research

AI Protein Structure Modeling Platforms in Antibody Research

Biointron 2024-01-24 Read time: 4 mins
AlphaFold2.jpg
Diagram of AlphaFold2 architecture. Image credit: DOI: 10.1038/s41586-021-03819-2

In the rapidly advancing landscape of antibody research, several machine learning techniques have emerged as valuable tools to predict protein-protein interactions. Examples of these methods include creating structural models of proteins, CDR loop structures, and antibody-antigen 3D structure libraries. Artificial intelligence (AI)-driven protein structure modeling platforms such as AlphaFold2 and IgFold are particularly exciting, paving the way to predicting accurate antibody-antigen interactions.


AlphaFold

AlphaFold2 was first showcased by DeepMind in 2020 at CASP14 (14th Critical Assessment of Techniques for Protein Structure Prediction), where AlphaFold2 structures were demonstrated to be vastly more accurate than competing methods by predicting protein folding by constructing in silico models from proteins’ amino acid sequences.1 It’s median backbone accuracy was 1.84 Å r.m.s.d.95 higher than the next best performing method. AlphaFold2 directly processes multiple sequence alignments for highly accurate protein structure prediction and has been used in applications in molecular replacement and interpreting cryogenic electron microscopy maps.2,3 

In antibody research, Yin et al. (2022) used AlphaFold2 to model antibody-antigen complexes but had low success rates, finding that AF2 faces difficulties in handling adaptive immune recognition. Gao et al. (2022), however, successfully demonstrated that AF2Complex, an AlphaFold2-based system, could be adapted to predict the structure of protein complexes at much higher accuracy than classical docking approaches.4


IgFold

In 2023, Ruffolo et al. developed a fast deep learning method for antibody structure prediction at an even better quality than AlphaFold, and at a much faster pace (under 25 seconds).5 By using a pre-trained language model on 558 million natural antibody sequences and graph networks, IgFold directly predicts backbone atomic coordinates which define antibody structure.

This breakthrough allows for potential antibody-antigen prediction accuracy that was previously infeasible. The researchers were able to predict structures for 1.4 million paired antibody sequences, providing structural insights to 500 times more antibodies than those that had been experimentally characterized. In addition, it offers the capabilities for robust incorporation of template structures and support for nanobody modeling. As of now, the main barrier in further developing these AI models is the low availability of experimentally determined structures to help predict how an antibody may bind to a target antigen.


At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Graves, J., Byerly, J., Priego, E., Makkapati, N., Parish, S. V., Medellin, B., & Berrondo, M. (2020). A Review of Deep Learning Methods for Antibodies. Antibodies, 9(2). https://doi.org/10.3390/antib9020012

  2. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A., Ballard, A. J., Cowie, A., Nikolov, S., Jain, R., Adler, J., Back, T., . . . Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583-589. https://doi.org/10.1038/s41586-021-03819-2

  3. Yin, R., Feng, B. Y., Varshney, A., & Pierce, B. G. (2022). Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants. Protein Science, 31(8), e4379. https://doi.org/10.1002/pro.4379

  4. Gao, M., Nakajima An, D., Parks, J. M., & Skolnick, J. (2022). AF2Complex predicts direct physical interactions in multimeric proteins with deep learning. Nature Communications, 13(1), 1-13. https://doi.org/10.1038/s41467-022-29394-2

  5. Ruffolo, J. A., Chu, L., Mahajan, S. P., & Gray, J. J. (2023). Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies. Nature Communications, 14(1), 1-13. https://doi.org/10.1038/s41467-023-38063-x


Subscribe to our ブログ

Recent ブログ

The therapeutic efficacy of antibodies is closely related to their ability to recognize and bind specific epitopes on target antigens. Epitopes, or antigenic determinants, are a group of amino acids or other chemical groups that are part of a molecule to which an antibody attaches itself. Epitope characterization can help reveal the mechanism of antibody binding and apply intellectual property (patent) protection for novel antibodies, in addition to designing antibodies with high specificity and minimal cross-reactivity.

Jul 12, 2024
ブログ

Understanding the differences between antibody specificity and selectivity is essential for designing and interpreting antibody-based assays in research for experimental accuracy and data interpretation. Antibody specificity refers to an antibody's ability to recognize and bind to a particular epitope—a unique part of an antigen that elicits an immune response.

Jul 10, 2024
ブログ

Antibody-based assays are essential tools in biomedical research, providing the means to detect, quantify, and visualize specific proteins or antigens within complex biological samples. These assays' efficacy hinges on the antibodies' precise properties. While affinity, avidity, specificity, and selectivity are fundamental to antibody performance, the ultimate impact of these properties is heavily influenced by the experimental context in which the antibody is employed.

Jul 08, 2024
ブログ

Biologics, particularly antibodies, have become indispensable in biomedical research and therapeutic development. Research-use-only (RUO) biologics play a pivotal role in preclinical studies, providing researchers with the necessary tools to explore antibody functions and therapeutic potential in vivo.

Jul 04, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。